Gainers
- Lipella Pharmaceuticals LIPO stock moved upwards by 110.0% to $6.53 during Wednesday's pre-market session. The market value of their outstanding shares is at $37.5 million.
- Biora Therapeutics BIOR stock moved upwards by 48.7% to $8.03. The company's market cap stands at $71.6 million.
- Hepion Pharmaceuticals HEPA shares rose 38.21% to $0.63. The market value of their outstanding shares is at $48.3 million.
- Aprea Therapeutics APRE stock rose 31.75% to $0.6. The company's market cap stands at $31.7 million.
- Veradigm MDRX stock moved upwards by 18.47% to $21.1. The company's market cap stands at $2.3 billion.
- Werewolf Therapeutics HOWL stock rose 18.38% to $2.64. The company's market cap stands at $81.1 million.
Losers
- Novo Integrated Sciences NVOS shares declined by 9.5% to $0.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.5 million.
- Apexigen APGN shares declined by 9.1% to $1.7. The company's market cap stands at $38.3 million.
- Prenetics Global PRE shares declined by 8.82% to $2.07. The company's market cap stands at $245.9 million.
- Vallon Pharmaceuticals VLON stock fell 7.33% to $0.29. The market value of their outstanding shares is at $3.9 million.
- NeuroMetrix NURO shares fell 7.15% to $1.54. The market value of their outstanding shares is at $11.9 million.
- Kiora Pharmaceuticals KPRX shares decreased by 6.32% to $3.56. The company's market cap stands at $4.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BIORBiora Therapeutics Inc
$0.5505-12.2%
HEPAHepion Pharmaceuticals Inc
$0.5035-4.82%
HOWLWerewolf Therapeutics Inc
$1.591.27%
KPRXKiora Pharmaceuticals Inc
$3.13-3.37%
LIPOLipella Pharmaceuticals Inc
$2.694.67%
MDRXVeradigm Inc
$6.86-27.9%
NURONeuroMetrix Inc
$3.90-%
NVOSNovo Integrated Sciences Inc
--%
PREPrenetics Global Ltd
$6.009.51%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in